Eric Anderson Email and Phone Number
Eric Anderson's Location
Bethlehem, Pennsylvania, United States, United States
Eric Anderson's Contact Details
Eric Anderson work email
- Valid
- Valid
- Valid
- Valid
- Valid
Eric Anderson personal email
n/a
Eric Anderson phone numbers
About Eric Anderson
Eric Anderson is a Chief Science Officer at Mussel Polymers, Inc. at Mussel Polymers, Inc.. He possess expertise in biotechnology, molecular biology, lifesciences, drug discovery, biochemistry and 38 more skills.
Eric Anderson's Current Company Details
Eric Anderson Work Experience Details
-
Chief Science OfficerMussel Polymers, Inc. Jan 2020 - PresentBethlehem, Pa, UsMussel Polymers Inc develops adhesives that bind strongly in wet and moist environments. Based on the work of Professor Jon Wilker of Purdue University, our biomemetic adhesives are nontoxic and effective in a broad array of applications. MPI was spun out of Purdue University by Wardenclyffe Ventures LLC.
-
Chief Operating Officer, Co-FounderWardenclyffe Chemicals, Inc. Oct 2017 - PresentWardenclyffe Chemicals Inc. works with inventors, entrepreneurs, university professors and technology transfer offices to take inventions from the laboratory to the marketplace. Our approach is efficient and produces results. 1. Our team rapidly assesses if there is a match with our expertise and a market for the technology. 2. We then meet with the inventor/tech team and evaluate the stage of technology development to determine what resources are necessary to develop prototypes for industry testing. 3. At this point we may option the technology and conduct a much deeper technology and market assessment generally lasting 3-6 months. 4. Finally we will license the technology, develop our business plan, assemble our team and finance the venture. Our investors are seasoned tech savvy entrepreneurs. Over the past two years we have evaluated hundred of technologies, met with approximately 20 technology teams, optioned three technologies, and launched one venture (solar technology). We are currently evaluating a drug-device combination product, innovative adhesives, two IoT devices, and are developing two of our own service ventures. We are not interested in early stage drug discovery or invasive medical devices. Disruptive technologies with prototypes and strong IP positions are of particular interest. Please feel free to contact us to discuss your ideas. -
Managing DirectorProspect Translational Research, Llc Apr 2015 - Present
-
Director, Finance And Licensing (2011-14) And Associate Director, Head Of Bd (2008-11)Chromocell Corporation Jan 2008 - May 2014North Brunswick, Nj, UsBiotechnology company utilizing a novel platform technology to discover and develop food flavorings and analgesics. Underwent explosive growth from 2010-2013.► Managed several development and operating functions - Business Development, Finance, Information Technology, Human Resources, Knowledge Management, and Communications.► Devised novel royalty terms for multi-year research and development contracts with The Coca-Cola Corporation and Nestlé S.A.► Oversaw renovation of corporate information systems: Enterprise Resource Planning (ERP) system, intranet, Human Resources Information System, new email / calendaring system.► Assessed, planned, and oversaw implementation of financial management processes to meet needs of rapid expansion and operating capacity: systematized cost accounting, created company budget, developed forecasting models, developed management reporting, and created written financial policies. -
Licensing Associate, Office Of Cooperative ResearchYale University School Of Medicine Jul 2007 - Jul 2008New Haven, Ct, UsUniversity technology transfer office licensing Yale’s biomedical intellectual property.► Manage relationships with a portfolio of Yale life sciences faculty members. Perform scientific, market research to identify basic research projects with commercial application.► Secure and manage intellectual property protection on faculty inventions.► Market faculty inventions to potential commercial partners. Estimate commercial value of intellectual property and negotiate licensing terms with interested companies.► Negotiate / manage agreements with partner universities regarding joint intellectual property.► Analyze comparable technologies and deal terms for two Yale-affiliated start-up companies. -
Manager, Business DevelopmentHistorx, Inc Jun 2005 - Aug 2006Biotechnology start-up commercializing a diagnostic test for personalized breast cancer treatment.► Developed a start-up biotechnology company by working in numerous capacities - everything from managing software development to manning the company booth at trade meetings.► Collaborated with scientists and business development officers at client pharmaceutical and biotechnology companies to design contract research studies.► Determined project costs with HistoRx scientists, and set project price with the CEO.► Assisted CEO in negotiating price and research contract terms with client companies.► Closed roughly $2M in contract research deals.
-
ConsultantHistorx, Inc 2006 - 2006► Identified sources of research funding for exploratory application of HistoRx technology to the field of toxicology.► Secured funding as the sole author of a successful Phase I Small Business Innovation Research (SBIR) grant application (PHS 2007-1, 102). This application, “AQUA® Analysis of Toxicologic Response in Rodents,” garnered $100K.
-
American Cancer Society - John Peter Hoffman Postdoctoral FellowYale University School Of Medicine Sep 1999 - Apr 2004New Haven, Ct, UsConducted independent, original basic research in the field of cellular biology.► Conceived, planned and executed original cell biology research in the laboratory of Dr. Ira Mellman, Chairman of Cell Biology at Yale.► Initiated and managed key strategic collaborations with research laboratories at Yale and other universities. ► Research yielded several peer-reviewed research papers (see “Publications”).
-
Co-Founder And ConsultantHedral Therapeutics, Incorporated Apr 1994 - Sep 1994My first laboratory research project was in the Laboratory of Gary Thomas at the Vollum Institute (Oregon Health and Science University). This project was to characterize the novel anti-viral agent “Alpha1-PDX.”► Led research project to demonstrate that #1-PDX was an effective anti-viral agent under experimental conditions.► Published our results in the Journal of Biological Chemistry and used the publication data as a foundation for a patent. (See “Selected Publications” and “Patent.”)► Collaborated with Gary Thomas and others to launch a start-up biotechnology company with seed funding from ICOS.► Served as a scientific consultant and co-founder of Hedral Therapeutics.► Led a group of technicians to implement a strategy to purify #1-PDX for research.
-
Senior Reactor OperatorReed Reactor Facility Aug 1990 - Dec 1992I served as a member of a team of students and faculty responsible for the operation of a TRIGA Mark I nuclear reactor at the Reed Reactor Facility at Reed College.► Passed Nuclear Regulatory Commission-administered written and oral exams on nuclear physics and reactor operations.► Ran the nuclear reactor during research operations while supervising trainees.► Inspected and maintained the reactor and reactor facility.
Eric Anderson Skills
Biotechnology
Molecular Biology
Lifesciences
Drug Discovery
Biochemistry
Life Sciences
Cell Biology
Cell Culture
Pharmaceutical Industry
Technology Transfer
Clinical Development
Assay Development
Strategy
Oncology
Biopharmaceuticals
Strategic Planning
Immunology
Management
Clinical Trials
Genomics
Drug Development
Cell
In Vitro
Business Development
Neuroscience
Infectious Diseases
Protein Chemistry
Pharmacology
Cancer
Medical Devices
R&d
Elisa
Commercialization
Licensing Negotiations
Grant Writing
Business Strategy
Corporate Finance
Information Technology
Human Resources
Contract Negotiation
Royalties
Growing Businesses
Research
Eric Anderson Education Details
-
Yale School Of ManagementMba -
Oregon Health & Science UniversityCell Biology
-
Reed CollegeBiology
Frequently Asked Questions about Eric Anderson
What company does Eric Anderson work for?
Eric Anderson works for Mussel Polymers, Inc.
What is Eric Anderson's role at the current company?
Eric Anderson's current role is Chief Science Officer at Mussel Polymers, Inc..
What is Eric Anderson's email address?
Eric Anderson's email address is er****@****ale.edu
What is Eric Anderson's direct phone number?
Eric Anderson's direct phone number is +191769*****
What schools did Eric Anderson attend?
Eric Anderson attended Yale School Of Management, Oregon Health & Science University, Reed College.
What skills is Eric Anderson known for?
Eric Anderson has skills like Biotechnology, Molecular Biology, Lifesciences, Drug Discovery, Biochemistry, Life Sciences, Cell Biology, Cell Culture, Pharmaceutical Industry, Technology Transfer, Clinical Development, Assay Development.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial